Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations.

Saladini F, Giannini A, Boccuto A, Dragoni F, Appendino A, Albanesi E, Vicenti I, Zazzi M.

Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01717-19. doi: 10.1128/AAC.01717-19. [Epub ahead of print]

PMID:
31611362
2.

Drug consumption and melanocytic nevi: correlation between oral contraceptives or hormone replacement therapy and a high melanocytic nevi count.

Colucci R, Buzzoni C, Dragoni F, Traniello Gradassi A, Galeone M, Crocetti E, Moretti S.

Eur J Cancer Prev. 2019 Sep 16. doi: 10.1097/CEJ.0000000000000545. [Epub ahead of print]

PMID:
31567537
3.

Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients.

Colucci R, Conti R, Dragoni F, Cammi A, Cianferotti L, Brandi ML, Moretti S.

Int J Vitam Nutr Res. 2019 Aug 15:1-5. doi: 10.1024/0300-9831/a000605. [Epub ahead of print]

PMID:
31414974
4.

Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A.

Vicenti I, Lai A, Giannini A, Boccuto A, Dragoni F, Saladini F, Zazzi M.

J Clin Virol. 2019 Feb;111:12-18. doi: 10.1016/j.jcv.2018.12.007. Epub 2018 Dec 19.

PMID:
30594700
5.

The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro.

Giannini A, Vicenti I, Materazzi A, Boccuto A, Dragoni F, Zazzi M, Saladini F.

J Antimicrob Chemother. 2019 Mar 1;74(3):607-613. doi: 10.1093/jac/dky479.

PMID:
30462235
6.

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events.

Dragoni F, Chiarotti F, Iori AP, La Rocca U, Cafolla A.

Thromb J. 2018 Oct 22;16:26. doi: 10.1186/s12959-018-0181-5. eCollection 2018.

7.

Individual benefits of enoxaparin treatment in branch vein occlusion.

Dragoni F, Kaarniranta K.

Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1031-1033. doi: 10.1007/s00417-017-3854-z. Epub 2017 Dec 1. No abstract available.

PMID:
29192333
8.

Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.

Vicenti I, Boccuto A, Giannini A, Dragoni F, Saladini F, Zazzi M.

Virus Res. 2018 Jan 15;244:64-70. doi: 10.1016/j.virusres.2017.11.003. Epub 2017 Nov 4.

PMID:
29113824
9.

No Association between Vitiligo and Obesity: A Case-Control Study.

Dragoni F, Conti R, Cazzaniga S, Colucci R, Pisaneschi L, Naldi L, Moretti S.

Med Princ Pract. 2017;26(5):421-426. doi: 10.1159/000481436. Epub 2017 Sep 12.

10.

Can environmental factors contribute in triggering vitiligo and associated autoimmune thyroid diseases? Possible connection to the Chernobyl nuclear accident.

Galeone M, Colucci R, Dragoni F, Moretti S.

G Ital Dermatol Venereol. 2018 Oct;153(5):729-730. doi: 10.23736/S0392-0488.17.05645-0. Epub 2017 Sep 8. No abstract available.

PMID:
28895374
11.

Treatment of recurrent pilonidal cysts with nd-YAG laser: report of our experience.

Dragoni F, Moretti S, Cannarozzo G, Campolmi P.

J Dermatolog Treat. 2018 Feb;29(1):65-67. doi: 10.1080/09546634.2017.1329513. Epub 2017 May 30.

PMID:
28521574
12.

Subungual Eccrine Porocarcinoma: Rare but Possible.

Palleschi GM, Dragoni F, Urso C.

Dermatol Surg. 2017 Jul;43(7):995-996. doi: 10.1097/DSS.0000000000001123. No abstract available.

PMID:
28328706
13.

Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening.

Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S.

Biomed Res Int. 2016;2016:8065765. Epub 2016 Sep 22.

14.

Agroindustrial residues and energy crops for the production of hydrogen and poly-β-hydroxybutyrate via photofermentation.

Corneli E, Adessi A, Dragoni F, Ragaglini G, Bonari E, De Philippis R.

Bioresour Technol. 2016 Sep;216:941-7. doi: 10.1016/j.biortech.2016.06.046. Epub 2016 Jun 16.

PMID:
27341463
15.

Efficacy of Rhodamine Light in the Treatment of Superficial Vascular Lesions of the Face.

Campolmi P, Cannarozzo G, Dragoni F, Conti R, Moretti S.

Med Princ Pract. 2016;25(5):477-82. doi: 10.1159/000446987. Epub 2016 May 23.

16.

Energy conversion of biomass crops and agroindustrial residues by combined biohydrogen/biomethane system and anaerobic digestion.

Corneli E, Dragoni F, Adessi A, De Philippis R, Bonari E, Ragaglini G.

Bioresour Technol. 2016 Jul;211:509-18. doi: 10.1016/j.biortech.2016.03.134. Epub 2016 Mar 28.

PMID:
27038259
17.

Polycystic ovary syndrome and vitiligo: simple association or tight connection?

Conti R, Manni C, Colucci R, Dragoni F, Moretti S.

G Ital Dermatol Venereol. 2016 Dec;151(6):715-716. Epub 2016 Mar 22. No abstract available.

PMID:
27002301
18.

Anticoagulant therapy with rivaroxaban in a young patient  with paroxysmal nocturnal hemoglobinuria.

Dragoni F, Chiarotti F, Lombardi L, Iori AP, Cafolla A.

Clin Case Rep. 2015 Oct;3(10):790-2. doi: 10.1002/ccr3.342. Epub 2015 Aug 26.

19.

Hair and Scalp Disorders in a Tuscan Pediatric Dermatological Outpatient Clinic: A Clinical and Epidemiological Evaluation.

Conti R, Colucci R, Arunachalam M, Berti S, Fabroni C, De Martino M, Dragoni F, Lazzeri L, Pisaneschi L, Moretti S.

Med Princ Pract. 2016;25(1):67-71. doi: 10.1159/000439466. Epub 2015 Oct 1.

20.

Oxidative stress and immune system in vitiligo and thyroid diseases.

Colucci R, Dragoni F, Moretti S.

Oxid Med Cell Longev. 2015;2015:631927. doi: 10.1155/2015/631927. Epub 2015 Mar 9. Review.

21.

Effectiveness and safety of therapy with vitamin K antagonists in Italian patients aged 80 years or older: a multicentre retrospective study comparing the Zeus algorithm with the PARMA algorithm or manual therapy.

Cafolla A, Manisco L, Baldacci E, Porcu A, Campanelli M, Cursano MC, Rossi E, Dragoni F, Foà R.

Drugs Aging. 2015 Mar;32(3):235-41. doi: 10.1007/s40266-015-0247-z.

PMID:
25721557
22.

Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients.

Colucci R, Lotti F, Arunachalam M, Lotti T, Dragoni F, Benvenga S, Moretti S.

Arch Environ Contam Toxicol. 2015 Aug;69(2):181-90. doi: 10.1007/s00244-015-0138-7. Epub 2015 Feb 21.

PMID:
25700983
23.

Autoimmune thyroid disease in Italian patients with non-segmental vitiligo.

Arunachalam M, Pisaneschi L, Colucci R, Dragoni F, Conti R, Moretti S.

Eur J Dermatol. 2014 Sep-Oct;24(5):625-6. doi: 10.1684/ejd.2014.2396. No abstract available.

PMID:
25445093
24.

Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment.

Colucci R, Dragoni F, Conti R, Pisaneschi L, Lazzeri L, Moretti S.

Dermatol Ther. 2015 Jan-Feb;28(1):17-21. doi: 10.1111/dth.12172. Epub 2014 Oct 6.

PMID:
25285994
25.

High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients.

Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, Moretti S.

Br J Dermatol. 2014 Oct;171(4):786-98. doi: 10.1111/bjd.13286. Epub 2014 Oct 1.

PMID:
25059078
26.

Milia-like idiopathic calcinosis cutis in the absence of Down's syndrome.

Conti R, Arunachalam M, Colucci R, Dragoni F, Pisaneschi L, Lazzeri L, Berti S, Battini ML, Franchi A, Moretti S.

G Ital Dermatol Venereol. 2014 Apr;149(2):276-8. No abstract available.

PMID:
24819651
27.

Autoimmune polyglandular type IIIc syndrome associated with Vogt-Koyanagi-Harada syndrome and common variable immunodeficiency.

Colucci R, Galeone M, Conti R, Arunachalam M, Pisaneschi L, Lazzeri L, Dragoni F, Moretti S.

G Ital Dermatol Venereol. 2015 Oct;150(5):633-5. Epub 2014 Apr 15. No abstract available.

PMID:
24736459
28.

Segmental neurofibromatosis type 1: a frequently underestimated disease.

Dragoni F, Bassi A, Conti R, Moretti S, Campolmi P.

G Ital Dermatol Venereol. 2013 Dec;148(6):706-7. No abstract available.

PMID:
24442057
29.

Suitability of giant reed (Arundo donax L.) for anaerobic digestion: effect of harvest time and frequency on the biomethane yield potential.

Ragaglini G, Dragoni F, Simone M, Bonari E.

Bioresour Technol. 2014;152:107-15. doi: 10.1016/j.biortech.2013.11.004. Epub 2013 Nov 11.

PMID:
24287451
30.

Successful treatment of acne keloidalis nuchae resistant to conventional therapy with 1064-nm ND:YAG laser.

Dragoni F, Bassi A, Cannarozzo G, Bonan P, Moretti S, Campolmi P.

G Ital Dermatol Venereol. 2013 Apr;148(2):231-2. No abstract available.

PMID:
23588150
31.

Non-segmental vitiligo and psoriasis comorbidity - a case-control study in Italian patients.

Arunachalam M, Dragoni F, Colucci R, Berti S, Crocetti E, Galeone M, Conti R, Moretti S.

J Eur Acad Dermatol Venereol. 2014 Apr;28(4):433-7. doi: 10.1111/jdv.12117. Epub 2013 Feb 26.

PMID:
23441884
32.

Ethical responsibility when dermatological signs reflect genetic disease.

Arunachalam M, Colucci R, Galeone M, Dragoni F, Berti S, Moretti S.

G Ital Dermatol Venereol. 2012 Oct;147(5):508-9. No abstract available.

PMID:
23007260
33.

Autoimmune signals in non-segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures.

Arunachalam M, Colucci R, Berti S, Kline JA, Lotti T, Lotti F, Dragoni F, Moretti S.

J Eur Acad Dermatol Venereol. 2013 Aug;27(8):961-6. doi: 10.1111/j.1468-3083.2012.04614.x. Epub 2012 Jun 15.

PMID:
22703111
34.

Misdiagnosis and patient negation: a case of universal vitiligo.

Colucci R, Arunachalam M, Dragoni F, Galeone M, Berti S, Moretti S.

Eur J Dermatol. 2012 May-Jun;22(3):423-4. doi: 10.1684/ejd.2012.1708. No abstract available.

PMID:
22640969
35.

Oral anticoagulant therapy in Italian patients 80 yr of age or older with atrial fibrillation: a pilot study of low vs. standard PT/INR targets.

Cafolla A, Campanelli M, Baldacci E, Potasso L, Bochicchio R, Dragoni F, Foà R.

Eur J Haematol. 2012 Jul;89(1):81-6. doi: 10.1111/j.1600-0609.2012.01786.x. Epub 2012 May 4.

PMID:
22519759
36.

"Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study.

Cafolla A, Melizzi R, Baldacci E, Pignoloni P, Dragoni F, Campanelli M, Caraccini R, Foà R.

Thromb Res. 2011 Oct;128(4):325-30. doi: 10.1016/j.thromres.2011.04.012. Epub 2011 May 19.

PMID:
21600633
37.

Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study.

Dragoni F, Chiarotti F, Rosano G, Simioni P, Tormene D, Mazzucconi MG, Cafolla A, Avvisati G.

Thromb Res. 2011 Feb;127(2):85-90. doi: 10.1016/j.thromres.2010.11.013. Epub 2010 Dec 18.

PMID:
21172722
38.

Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study.

Dragoni F, Iori AP, Pignoloni P, Minotti C, Chiarotti F, Mazzucconi MG, Mengarelli A, Arcese W, Foà R, Avvisati G.

Br J Haematol. 2010 Aug;150(4):492-4. doi: 10.1111/j.1365-2141.2010.08230.x. Epub 2010 Jun 15. No abstract available.

PMID:
20560962
39.

Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.

Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.

Ann Hematol. 2007 Apr;86(4):263-70. Epub 2007 Jan 16.

PMID:
17225113
40.

The role of real-time ultrasonography in predicting esophageal varices in hemophiliacs co-infected with hepatitis C and human immunodeficiency virus.

Dragoni F, Gentile G, Cartoni C, Chiarotti F, Puopolo M, Mazzucconi MG, De Matteis LM, Pirillo M, Martino P.

Haematologica. 2005 Feb;90(2):207-13.

41.

Effect of high intakes of fruit and vegetables on redox status in type 2 onset diabetes: a pilot study.

Giammarioli S, Filesi C, Vitale B, Cantagallo A, Dragoni F, Sanzini E.

Int J Vitam Nutr Res. 2004 Sep;74(5):313-20.

PMID:
15628668
42.

A long-term study of young patients with essential thrombocythemia treated with anagrelide.

Mazzucconi MG, Redi R, Bernasconi S, Bizzoni L, Dragoni F, Latagliata R, Santoro C, Mandelli F.

Haematologica. 2004 Nov;89(11):1306-13.

43.

Gender differences in cardiovascular risk factors.

Mercuro G, Zoncu S, Dragoni F.

Ital Heart J. 2003 Jun;4(6):363-6. Review.

PMID:
12898798
44.

Folate status and homocysteine level in Italian patients aged under 60 on oral anticoagulant therapy.

Cafolla A, Dragoni F, Puopolo M, Ruzzi L, Chiarotti F, Silvestri L, Bongarzoni V, Simioni P.

Ann Med. 2003;35(2):140-4.

PMID:
12795342
45.

Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors.

Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, De Luca AM, Funaro D, Scott CS.

Atherosclerosis. 2002 Jul;163(1):105-11.

PMID:
12048127
46.

ProC global: a new automated screening assay for the evaluation of total function of the protein C system.

Dragoni F, Tormene D, Simioni P, Arcieri P, Avvisati G, Girolami A.

Clin Appl Thromb Hemost. 2001 Oct;7(4):351-5.

PMID:
11697723
47.

As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.

Dragoni F, Minotti C, Palumbo G, Faillace F, Redi R, Bongarzoni V, Avvisati G.

Thromb Res. 2001 Jan 15;101(2):45-51.

PMID:
11342205
48.

Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.

Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P, Petti MC, Meloni G, Mandelli F.

J Clin Oncol. 2001 Feb 1;19(3):756-61.

PMID:
11157028
49.

Folate status in Italian blood donors: relation to gender and smoking.

Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, Pastorelli D, Bedogni G, Scott S.

Haematologica. 2000 Jul;85(7):694-8.

50.

HIV-HCV RNA loads and liver failure in coinfected patients with coagulopathy.

Dragoni F, Cafolla A, Gentile G, Mazzucconi MG, Vella S, Di Corpo U, Tosti ME, Pisani G, Donato V, Martino P.

Haematologica. 1999 Jun;84(6):525-9.

Supplemental Content

Loading ...
Support Center